|
Volumn 22, Issue 2, 2004, Pages 136-
|
China pushes liver proteomics
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
PROTEOME;
BIOTECHNOLOGY;
CHINA;
COST;
DRUG INDUSTRY;
FINANCIAL MANAGEMENT;
GENE EXPRESSION PROFILING;
GOVERNMENT;
HEPATITIS;
HUMAN;
INVESTMENT;
LICENSING;
LIVER;
LIVER DISEASE;
MEDICAL GENETICS;
NOTE;
PILOT STUDY;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
PROTEIN PROTEIN INTERACTION;
PROTEOMICS;
RESOURCE ALLOCATION;
ANTIBODIES;
BIOTECHNOLOGY;
CHINA;
FINANCING, GOVERNMENT;
GOVERNMENT PROGRAMS;
HUMANS;
LIVER;
LIVER DISEASES;
PROTEIN INTERACTION MAPPING;
PROTEOMICS;
RESEARCH;
|
EID: 0742305701
PISSN: 10870156
EISSN: None
Source Type: Journal
DOI: 10.1038/nbt0204-136 Document Type: Note |
Times cited : (8)
|
References (0)
|